Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Motor Activity × Nadolol × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Hemangioma, Capillary 2 Motor Activity 1 Lymphoma 1 Liver Cirrhosis 1 Leukemia 1 Hemangioma 1 Carcinoma, Hepatocellular 1

Interventions

Exercise 214 Resistance Training 26 Surveys and Questionnaires 19 High-Intensity Interval Training 16 Walking 13 Exercise Therapy 13 Diet 13 Preoperative Exercise 12 Methods 12 Standard of Care 11 Control Groups 11 Nutritional Status 8 Counseling 7 Nutrition Assessment 6 Motivational Interviewing 5 Fitness Trackers 5 Diet Therapy 5 Physical Therapy Modalities 4 Interviews as Topic 4 Cognitive Behavioral Therapy 4 methyl hydroxyethyl cellulose 3 Wearable Electronic Devices 3 Therapeutics 3 Rehabilitation 3 Palliative Care 3 Nutritional Support 3 Educational Status 3 Diet, Mediterranean 3 Behavior Therapy 3 pembrolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06643221 2024-10-16

Allo-X

University of Arizona

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡